Vyant Bio, Inc.

Good afternoon and welcome to the ViantBio third quarter 2021 conference call and webcast. Today, November 11, 2021, the company issued a press release summarizing results for the third quarter 2021 and will be filing its Form 10-Q tomorrow morning before the market opens at 9.30 a.m. Eastern Time. Today's discussion will provide an overview of activities in the quarter and is being recorded and a replay of the webcast will be available on the ViantBio website following the call. Alternatively, the link can be sent to you by contacting ir at ViantBio.com. All participants on this call will be in a listen-only mode during the presentation. The presentation will be followed by a question-and-answer session. At this time, I would now like to turn the conference over to Jay Roberts, Chief Executive Officer of ViantBio. Please go ahead, sir.

Thank you, operator. Thank you all for joining the ViantBio investor conference call and webcast for the third quarter of 2021. We're pleased to have completed our second full quarter as ViantBio. Now that the merger and related integration activities are completed, we have directed our full focus on executing our business plan. It is also a great pleasure to speak with you today to share our enthusiasm and to give you some insight into how we envision the near-term future of ViantBio. Additionally, we're going to present the financial results for the third quarter ending September 30th, 2021. On the call with me today is ViantBio's Chief Financial Officer, Andy LaFrance, and our Chief Scientific Officer, Bob Fremaux. Following the Safe Harbor statement, I will provide a strategic overview and update on recent corporate developments and the vision ahead. Then Andy will take us through a brief financial update and discuss key accounting matters for the third quarter. I will make some closing remarks, and then we will open up the lines for questions for Andy, Bob, and me. I will now turn the call over to our CFO, Andy LaFrance.

Thank you, Jay, and welcome to all. We would like to remind you that various comments about future expectations, plans, and prospects constitute forward-looking statements for purposes of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Bio cautions that these forward-looking statements are subject to risks and uncertainties that may cause or ask results to differ materially from those indicated, including risks described in the company's filings with the FCC. Any forward-looking statements made on this conference call speak only as of today's date, Thursday, November 11, 2021, and Vine Bio does not intend to update any of these forward-looking statements to reflect events or circumstances that would occur after today's date. This conference call is also being recorded for audio rebroadcast on Vine Bio's website at www.vinebio.com. With that, I would like to turn the call back over to Jay Roberts.